AzTrials
AzTrials

Obstructive Sleep ApneaWe-PAPNCT04759157

We-PAP: A Couples-based Intervention for Sleep Apnea

A study testing Couples-based treatment and Standardized education in people with Obstructive Sleep Apnea, run by University of Utah at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to develop, refine and evaluate the feasibility of a novel couples-based intervention to improve adherence for patients with obstructive sleep apnea (OSA). Read more about this study

Who is it for?
Ages 50 to 85 years
Conditions the study is for
Obstructive Sleep Apnea
What is being tested?
Couples-based treatment and Standardized education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 siteUnited States
Study dates
16 Jun 2021to 31 Jan 2023
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient and partner inclusion criteria:
  • Age >=50
  • Access to cellular (active data plan) or Wi-Fi, in order to complete the telehealth intervention.
  • Patients inclusion criteria:
  • Diagnosed with OSA (AHI>10 or AHI>5 with impairment) and intend to start PAP treatment
  • PAP naïve or non-use of PAP for at least 3 years
Show all 11Show fewer
  • Married or cohabiting with a romantic partner for >1 year
  • Able to read/write English.
  • Partner inclusion criteria:
  • Able to read/write English
  • PROMIS sleep disturbance score >55 in either patient or partner, or desire to improve sleep.

Who cannot join

  • Patient only exclusion criteria:
  • 1. Concomitant OSA treatments (bariatric surgery planned in the next 3 months or bariatric surgery in the past year, ear nose and throat surgery for sleep apnea occurring in the 3 months before or planning for within the study period).
  • Exclusion criteria for both patient and partner include the following:
  • High risk or presence of moderate to severe comorbid sleep disorders (i.e., restless legs syndrome)
  • History of cognitive or neurological disorders (e.g., dementia, Parkinson's, Multiple Sclerosis)
  • Presence of major psychiatric disorders (e.g., schizophrenia, bipolar disorder), alcohol abuse reported on the Audit-C (score >4 for men, >3 for women), drug use (NIDA-Modified ASSIST score >3)
Show all 13Show fewer
  • Unstable or serious medical illness that would interfere with participation (cancer, renal disease on dialysis, moderate to severe COPD)
  • Use of ASV, VPAP or supplemental oxygen
  • Overnight work > 1x per month
  • Pregnancy/ desire to become pregnant in the study period
  • Current participation in behavioral sleep treatment (e.g., CBT-I) or completion of CBT-I in the past 3 years
  • Concurrent participation in another clinical trial
  • Caregiving for an infant < 2 years old or adult who requires overnight assistance.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Utah

    Salt Lake City, Utah, 84108

Other trials in United States

About this study

Official title: A Novel Couples- Based Sleep Health Intervention For Older Adults With Obstructive Sleep Apnea: Implications for Alzheimer's Disease Risk And Healthy Aging

The purpose of this study is to develop, refine and evaluate the feasibility of a novel couples-based intervention to improve adherence for patients with obstructive sleep apnea (OSA).

Read the detailed description

This study will develop and test a novel couples-based intervention for the treatment of OSA and sleep health among older couples. The focus of this study is patient who are starting CPAP treatment and their partners. Couples will be randomized to a 3-session sleep health intervention delivered via telehealth or to standard educational support for CPAP. The intervention is based on a transdiagnostic model of sleep and circadian disorders (TransS-C) and rooted in the idea that older adults with OSA are often also having other sleep problems, and that OSA is best treated in the couples context.

Being tested
Couples-based treatment, Standardized education
Keywords
OSA
Medical subject headings
Sleep Apnea, Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Couples-based treatmentBehavioural

    Couples will attend 3, video based sessions for couples-based treatment

  • Standardized educationOther

    Patients will receive standardized educational materials

Study groups in NCT04759157
Study groupRoleWhat they receive
Couples-based treatment- PatientExperimentalParticipants will attend 3, sessions (75, 50, 50 min) over video with a study therapist to discuss education about OSA and CPAP, strategies adjust to CPAP as a couple and techniques to improve sleep health.
Receives: Behavioral: Couples-based treatment
Couples-based treatment- PartnerExperimentalParticipants will attend 3, sessions (75, 50, 50 min) over video with a study therapist to discuss education about OSA and CPAP, strategies adjust to CPAP as a couple and techniques to improve sleep health.
Receives: Behavioral: Couples-based treatment
Information Control- PatientActive comparatorParticipants will receive treatment as usual and also standardized information about OSA and CPAP.
Receives: Other: Standardized education
Information Control- PartnerActive comparatorParticipants will receive treatment as usual and also standardized information about OSA and CPAP.
Receives: Other: Standardized education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment Feasibility

    Defined as the ability to achieve the recruitment goals of the study, to recruit approximately 3-4 couples per month over the study period (12 months)

    Measured: study duration

Secondary outcomes (2)
  1. Percentage of Days With PAP Use of 4 Hours or More

    The primary efficacy measure for this pilot trial was the percentage of days that patients used CPAP for 4 hours or more over the first 3 months. This 4 hour cutoff was selected becasue it is the minimum usage defined by Medicare and other insurance companies. We obtained patients' CPAP usage by downloading data from their machine using a remote dashboard. Data are only available for patients because partners were not using the treatment. This variable is defined as a proportion, calculated as the number of days with CPAP usage of 4 hours or more divided by the total number of days collected in the 3 month recording period. Scores can range from 0 (no days with use to 1, indicating all days with use of 4 hours or more).

    Measured: 3 months

  2. Self-reported Sleep Disturbance

    Patient sleep quality on the Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scale, 8 item, version 8b. Models evaluated change from baseline to 3 months. Raw are converted to t-scores, with a range of 28.9-76.5, a mean of 50 and a SD of 10. Higher scores indicate poorer sleep subjective quality.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2021
  2. Study start16 Jun 2021
  3. Primary completion16 Dec 2022
  4. Study completion31 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a dyadic study. Couples are randomly assigned as a dyad.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
84 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04759157
Sponsor's protocol ID
00135927
Other IDs
1R21AG067183-01A1
Acronym
We-PAP
Status last verified
Dec 2024
First submitted
13 Feb 2021
Last updated
10 Dec 2024
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be made available upon request

Publications

  • Baron KG, Gilles A, Sundar KM, Baucom BRW, Duff K, Troxel W. Rationale and study protocol for We-PAP: a randomized pilot/feasibility trial of a couples-based intervention to promote PAP adherence and sleep health compared to an educational control. Pilot Feasibility Stud. 2022 Aug 6;8(1):171. doi: 10.1186/s40814-022-01089-x.

    PubMed 35933417

Questions about this trial

What is this clinical trial studying?

A study testing Couples-based treatment and Standardized education in people with Obstructive Sleep Apnea, run by University of Utah at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 10 Dec 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recruitment Feasibility (time frame: study duration). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04759157, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Dec 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in